Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating iguratimod versus placebo in active primary Sjogren's syndrome to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Primary Sjögren Syndrome | Phase 2 | Status: UNKNOWN